Bioquell publishes norovirus information tools
4 December 2014 | By Bioquell
Norovirus season is upon us and Bioquell has issued tools to help combat the spread...
List view / Grid view
News
Bristol-Myers Squibb Foundation awards nine grants totaling more than $3.5 million to support care for high-risk patients with hepatitis B and C in China and India
4 December 2014 | By Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus (HBV) and hepatitis C virus (HCV) infection by focusing on the most vulnerable, high-risk patient populations...
Sagentia selected as lead development partner for Chrono Therapeutics’ wearable ‘smart’ smoking cessation device
3 December 2014 | By Sagentia
Sagentia, a global science, product and technology development company, announced today that it is working with Chrono Therapeutics on the development of SmartStop™, the world’s first programmable and wearable nicotine delivery device to help people quit smoking...
Age-related macular degeneration treatment market value to exceed $10 billion by 2023
3 December 2014 | By GlobalData
The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and Japan) will almost double in value from $5.1 billion in 2013 to $10.1 billion by 2023, according to research and consulting firm GlobalData.
Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study
3 December 2014 | By Prothena
Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study of NEOD001 in Patients With AL Amyloidosis...
NICE reverses decision on access to new blood cancer drug
2 December 2014 | By Roche
Victory for patients as NICE accepts Gazyvaro™ (obinutuzumab) for treatment of most common adult leukaemia1...
Ebola: Ask your questions LIVE to the Chief Medical Officer of the Ministry of Health and Sanitation of Sierra Leone
2 December 2014 | By The Republic of Sierra Leone
The Chief Medical Officer of the Ministry of Health and Sanitation, Dr Brima Kargbo, will host an online press conference on Wednesday, December 3rd, 2014 at 15 GMT...
Survivors take spotlight in new campaign to end West Africa’s Ebola outbreak
2 December 2014 | By Distributed by APO (African Press Organization) on behalf of #TackleEbola
The multimedia campaign is the first to directly engage Ebola survivors in delivering key protective messages...
Inventiva receives another positive opinion on orphan drug designation in the European Union for IVA337 – for Idiopathic Pulmonary Fibrosis
2 December 2014 | By Inventiva
This follows an earlier positive opinion for IVA337 in October regarding the treatment of Systemic Sclerosis (SSc)...
Exco InTouch address mHealth solutions in management of chronic conditions at 2014 mHealth Summit
2 December 2014 | By Exco InTouch
Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, will speak in two mHealth Solutions sessions focused on disease management at the annual mHealth Summit on Monday, 8th and Tuesday 9th December 2014...
Roche acquires Ariosa Diagnostics and enters the non-invasive prenatal test (NIPT) and cell-free DNA testing services markets
2 December 2014 | By Roche
Roche announced the acquisition of Ariosa Diagnostics, Inc. (Ariosa), a privately-held company based in San Jose, California, USA...
Bristol-Myers Squibb Foundation marks World AIDS Day by awarding $1.47 million in new grants to strengthen HIV-related services in five sub-Saharan countries
2 December 2014 | By The Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation marked World AIDS Day by announcing 12 new grants totaling $1.47 million that focus on strengthening community-based services in sub-Saharan Africa for adolescents and the elderly who are living with HIV and for HIV patients with comorbid female cancers or tuberculosis...
MWV’s MEMS™ System chosen for trials of HIV-prevention medication in Africa and India
2 December 2014 | By MWV
Global packaging company has received a grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials...
The emerging markets will comprise 1/3 of global pharma by 2017
1 December 2014 | By Kakushin Webinars
Dr. Gurpreet Sandhu, Reva Pharmachem Managing Director, shared the following in regard to Drug Manufacturing in Russia...
Application submitted to the EMA to expand the therapeutic indication for IMBRUVICA® (ibrutinib) to include treatment of Waldenström’s macroglobulinemia
1 December 2014 | By Janssen-Cilag International
Janssen-Cilag International NV (Janssen) announced today the submission of a Type II variation application to the European Medicines Agency (EMA) to vary the marketing authorisation for IMBRUVICA® (ibrutinib), to include a new therapeutic indication, the treatment of adult patients with Waldenström’s macroglobulinemia (WM). If approved, this latest regulatory submission will…
